“…Dihydroquinoxalinones are bioactive compounds of high interest, due to their anticancer [ 42 , 43 , 44 ] and anti-inflammatory [ 45 ] properties, as well as their activity against neurological diseases [ 46 ] ( Scheme 2 ). Dihydroquinaxolinone derivatives have been mainly synthesized via coupling of o -nitroaryl- or o -aminoaryl halides with amino acids [ 43 , 45 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 ], or transition metal-catalyzed asymmetric hydrogenation of the corresponding quinoxaline derivatives ( Scheme 2 ) [ 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 ]. However, these methods required air-sensitive catalysts, toxic organic solvents, and several ligands.…”